PROGRAMME OBJECTIVES
At the 13th World Conference on Lung Cancer, our objectives are to:
- Share and discuss recent advances in prevention, imaging, early detection and treatment of lung cancer
- Review advances in the molecular biology and pharmacogenomics of lung cancer and how they apply to personalizing medicine
- Discuss tobacco control methods being utilized throughout the world
- Evaluate results from recent clinical trials related to lung cancer and mesothelioma
- Review palliative care options for patients with lung cancer
- Support the career development of fellows and junior faculty with an interest in lung cancer
PROGRAMME HIGHLIGHTS
Educational Sessions
These sessions offer multidisciplinary explorations of focused topics related to thoracic oncology. Particular care
was taken to ensure that these sessions are integrated in terms of such issues as surgical, radiation, and medical
oncology; symptom management; health services research; global perspectives; and pathology, as appropriate.
Highlight of the Day Sessions
In these sessions, experts in the field will summarize the essence of the selected abstracts of clinical/
translational research presented on the previous day.
Interactive Grand Rounds Sessions
These sessions invite active participation of audience using interactive keypad technology. After a brief
introductory lecture, a typical case scenario will be presented for discussion with a series of questions for the
audience to answer.
Meet-the-Professor (MTP) Sessions
These sessions provide open discussion between recognized experts and session attendees, with an opportunity
for attendees to interact personally with the experts.
Mini-Symposia Sessions
In these sessions, reports on the latest scientific results, controversial issues, and emerging concepts will be
presented. Experts in the field place the studies in the appropriate context based on the strength of the evidence
and critically discuss the conclusions in terms of their applicability to clinical practice.
Plenary Sessions and Presidential Symposium
In Plenary sessions, several lectures which are of particular interest, Importance, and relevance to attendees, will be
presented. Top-scoring abstracts selected by the Scientific Committee will be presented in the Presidential Symposium.
Poster Display and Discussion Sessions
These sessions highlight selected abstracts of submitted papers in poster format. The posters are grouped by
topic or by the questions posed as a result of the research findings. The posters are on display for a specified
time, followed by a discussion and summarized review session in which experts provide commentary on the
research findings in a separate room.
Proffered Paper Sessions
These sessions include 10-minute didactic presentations of selected abstracts of scientific research in clinical
trials, basic and translational research by topics. Experts in the field serve as discussants to place research
findings into perspective.
Young Investigator’s Day
The Young Investigator’s Day, which is designed specifically for medical professionals in training and those in the
early stages of their career, will provide a unique opportunity to interact with recognized leaders in the field of
thoracic oncology. Sessions will also provide practical, treatment-oriented, and career-related information.
Satellite Symposia
Satellite Symposia sessions will be offered to Conference attendees free of charge. These will be sponsored by
a variety of pharmaceutical companies. See the “Programme at a Glance” for dates and times. Information on
speakers and specific topics will be available on the Conference website in 2009. You are encouraged to attend
these symposia as the topics have been chosen after consultation with the Scientific Committee and will
compliment the Plenary Sessions and Mini-Symposia of the Conference.
